SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-219901
Filing Date
2013-05-14
Accepted
2013-05-14 17:24:18
Documents
11
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d514751d10q.htm 10-Q 603127
2 EX-31.1 d514751dex311.htm EX-31.1 8990
3 EX-31.2 d514751dex312.htm EX-31.2 8963
4 EX-32.1 d514751dex321.htm EX-32.1 3983
5 EX-32.2 d514751dex322.htm EX-32.2 4001
  Complete submission text file 0001193125-13-219901.txt   3831007

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT kbio-20130331.xml EX-101.INS 478135
7 XBRL TAXONOMY EXTENSION SCHEMA kbio-20130331.xsd EX-101.SCH 39601
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE kbio-20130331_cal.xml EX-101.CAL 48285
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE kbio-20130331_def.xml EX-101.DEF 214833
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE kbio-20130331_lab.xml EX-101.LAB 304434
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kbio-20130331_pre.xml EX-101.PRE 253357
Mailing Address 260 EAST GRAND AVE SOUTH SAN FRANCISCO CA 94080
Business Address 260 EAST GRAND AVE SOUTH SAN FRANCISCO CA 94080 650.243.3100
KALOBIOS PHARMACEUTICALS INC (Filer) CIK: 0001293310 (see all company filings)

IRS No.: 770557236 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35798 | Film No.: 13842760
SIC: 2834 Pharmaceutical Preparations